Malaysia’s healthcare sector delivered a steady first quarter, supported by stronger patient volumes, improving case mix, and signs of recovery in the pharmaceutical segment. While medical tourism and structural demand continue to support growth, rising costs, currency volatility, and regulatory uncertainty are creating a more challenging operating environment. As the sector shifts from post-pandemic recovery towards a greater focus on earnings quality and sustainability, where will the next phase of growth come from?

Image Credit: Shutterstock